Bakuchi for Bone Health

Research suggests that Bakuchi (Psoralea corylifolia) and its constituent compounds — including psoralen, bakuchiol, corylin, bavachin, and polysaccharides — may support bone health through multiple mechanisms, including promoting osteoblast differentiation and mineralization, inhibiting osteoclast activity, and exerting estrogen-like effects on bone metabolism. Studies indicate these compounds show promise in preclinical models of osteoporosis, fracture healing, and diabetic bone loss, with several investigations pointing to specific molecular pathways such as ERK signaling, MAPK, and estrogen receptor signaling as likely mediators. The available evidence base consists predominantly of animal studies (primarily ovariectomized rodent models) and in vitro cell experiments, along with several narrative reviews synthesizing these findings, with no published human clinical trials identified among the reviewed literature. While the mechanistic and preclinical data are consistently supportive in direction, the absence of human trials means the translation of these findings to clinical benefit in people remains to be established.